MAXIGESIC® Double Action Pain & Fever Relief Film Coat Tablets 10s / 20s
MAXIGESIC® is a unique patented combination of Paracetamol 500mg and Ibuprofen 150mg proven to provide fast and effective double action relief from a wide range of pain symptoms. These tried and trusted active ingredients work together in combination to provide better pain relief than Paracetamol or Ibuprofen alone,1 and reduce fever and inflammation.
WARNING: Do NOT combine with any other Paracetamol or Ibuprofen containing medicines. Do not exceed the daily recommended dose.
Maxigesic® should not be taken: If you are allergic to ibuprofen, paracetamol, aspirin or other anti-inflammatory medicines, in the last 3 months of pregnancy, or in the presence of a stomach ulcer or stomach disorders, impaired liver or kidney function, or heart failure.
Reference: 1. 2 tablets of Maxigesic 4 times a day provides 78% more effective pain relief than Paracetamol 1000mg 4 times a day. Based on trial of post operative pain relief after removal of at least 2 wisdom teeth using US formulation (bioequivalent to SG formulation). Daniels et al (2018). Research sponsored by AFT Pharmaceutical Ltd.
Maxigesic® coated tablets (Paracetamol 500mg and Ibuprofen 150mg) are for the temporary relief of mild to moderate pain associated with headache, dental pain, period pain, migraine, backache, rheumatic pain, muscular pain, sore throat, and pain after vaccination. Maxigesic® also reduces fever. Maxigesic® is especially suitable for pain which requires stronger analgesia than ibuprofen or paracetamol alone. The usual dosage for Adults and Children over 12 years is 1–2 tablets taken every 6 hours with a full glass of water, as required, up to a maximum of 8 tablets in 24 hours. Do not take more than 8 tablets in a 24 hour period. Incorrect use can be harmful. Maxigesic®> is not recommended for children under 12 years. Do not use if you have kidney disease. Do not use if you have asthma or a stomach ulcer. Do not combine with any other Paracetamol or Ibuprofen containing medicines. Patent No. 128361.